NovaBay Pharmaceuticals, Inc. EV/Sales

EV/Sales of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.


Highlights and Quick Summary

Current EV/Sales of NovaBay Pharmaceuticals, Inc. is 1.22 (as of December 31, 2021)
  • EV/Sales for the quarter ending June 30, 2022 was 1.13 (a -10.91% decrease compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -56.32%
  • Annual EV/Sales for 2021 was 1.22 (a -7.59% decrease from previous year)
  • Annual EV/Sales for 2020 was 1.32 (a -20.57% decrease from previous year)
  • Annual EV/Sales for 2019 was 1.66 (a 99.51% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of NovaBay Pharmaceuticals, Inc.

Most recent EV/Salesof NBY including historical data for past 10 years.

Interactive Chart of EV/Sales of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 1.13 1.27
2021 1.22 2.6 2.32 2.83 1.22
2020 1.32 1.69 3.0 2.07 1.32
2019 1.66 0.79 3.22 1.72 1.66
2018 0.83 1.62 2.26 2.84 0.83
2017 3.3 4.0 3.51 3.71 3.3
2016 1.81 3.79 2.16 1.84 1.81
2015 1.13 5.6 15.53 24.54 1.13
2014 24.59 31.35 14.17 13.83 24.59
2013 9.77 13.16 5.6 6.49 9.77
2012 2.37 3.68 3.8 2.63 2.37
2011 1.84 0.76 1.84

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology